What you see is (not) what you get: tools for a non-radiologist to evaluate image quality in lung cancer

Medical imaging is an essential component of the diagnostic procedures performed in lung cancer. Next to that, it is also used for response assessment. The imaging modalities used in oncology have evolved from simple X-rays to computed tomography (CT)- and magnetic resonance imaging (MRI) scans. Nuclear imaging has innovated by the introduction of positron-emission tomography (PET) with several tracers being 18F-fludeoxyglucose (18F-FDG) most frequently used. An 18F-FDG-PET-scan using an integrated PET-CT scanner combined with a contrast enhanced CT is nowadays a standard staging technique in thoracic oncology.

Source: Lung Cancer - July 15, 2018 Category: Cancer & Oncology Authors: Evelyn E.C. de Jong, Lizza E.L. Hendriks, Wouter van Elmpt, Hester A. Gietema, Paul A.M. Hofman, Dirk K.M. De Ruysscher, Anne-Marie C. Dingemans Source Type: research